With drug pricing pressure building from the U.S., a healthcare-focused consortium of five European countries are calling for a “unified approach” to strengthen Europe’s pharmaceutical framework an | Facing drug pricing pressure from the U.S., Belgium, the Netherlands, Luxembourg, Austria and Ireland stressed the need for "collaborative efforts across the Union" in a June 10 statement.

In Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the country. | The CEO voiced his concerns about Germany's…